Identification of a SOCS1-edited TIL Therapy using CRISPR Screens in Mouse Syngeneic Tumor Models

Time: 12:00 pm
day: Applications in Drug Discovery & Screening Day 1 AM

Details:

  • Demonstrating the power of CRISPR screens in syngeneic tumor models for immunotherapy target identification
  • Highlighting the translatability of data generated in mouse models into human preclinical tumor models

Speakers: